Rankings / Mitochondria & Cellular Energy
Mitochondria & Cellular Energy
ATP, electron-transport, redox, and oxidative-stress agents — CoQ10/ubiquinol, urolithin A, methylene blue, hydrogen water, mitochondrial peptides.
| # | Compound | Ev | Bn | Sf | Grade · Score |
|---|---|---|---|---|---|
| 1 | CoQ10 (ubiquinone/ubiquinol) Electron transport cofactor | 8 | 6.5 | 9 | A+ 8.2 |
| 2 | Urolithin A Mitophagy inducer | 6 | 6.5 | 9 | B+ 7.3 |
| 3 | Alpha-lipoic acid (ALA) Antioxidant / mitochondrial | 6 | 5 | 9 | B+ 7.1 |
| 4 | Red light therapy / photobiomodulation (PBM) Light | 6 | 5 | 9 | B+ 7.1 |
| 5 | SS-31 (elamipretide) Mitochondrial peptide | 6 | 5 | 9 | B+ 7.1 |
| 6 | Hydrogen water / molecular hydrogen (H2) Antioxidant gas | 6 | 3.5 | 9 | B 6.8 |
| 7 | Ergothioneine Fungal amino acid | 4.5 | 5 | 9 | B 6.4 |
| 8 | Pyrroloquinoline quinone (PQQ) Mitochondrial biogenesis cofactor | 4.5 | 3.5 | 9 | B- 6.2 |
| 9 | Methylene blue Alternative electron carrier / MAOI / tau aggregation inhibitor | 6 | 5 | 3.5 | C High-risk profile 4.9 |
| 10 | BAM15 Mitochondrial uncoupler / exercise mimetic | 2 | 5 | 3 | D High-risk profile 2.9 |
Mitochondrial support is mechanistically seductive — everything runs on ATP, so a compound that "supports mitochondria" sounds universally useful. The human evidence is more modest than the mechanism suggests. This category rewards the few compounds with real randomised data and stays skeptical of the rest.
Human evidence by context
CoQ10 (ubiquinol) has its clearest evidence in statin-associated muscle symptoms and mitochondrial conditions, with mixed findings. Randomised urolithin A trials (2019, 2022) report measurable gains in mitochondrial and muscle-endurance markers associated with mitophagy. NAD+ precursors such as NMN and NR reliably raise NAD+ in humans, while clinical outcome data remain behind the mechanistic evidence.
The biohacker favourite with a real catch
Methylene blue has become a popular nootropic and "mitochondrial enhancer," and low-dose research describes electron-transport effects. It is also a drug with MAO-inhibiting activity and can cause serotonin syndrome when combined with SSRIs, SNRIs, or other serotonergic agents. Consumer-grade material may not meet pharmaceutical purity standards; these interaction and quality findings contribute to its safety context.
The rest
ALCAR (acetyl-L-carnitine), alpha-lipoic acid, PQQ, and red-light therapy populate the moderate-to-weak tiers: plausible mechanisms with small or inconsistent human trials. Their scores primarily reflect limited evidence rather than proof of no effect; each page reports its safety findings separately.
Frequently asked
Which mitochondrial compounds have comparatively stronger human evidence?
Urolithin A has randomised data showing modest improvements in mitochondrial and muscle-endurance markers. CoQ10 has a separate, more condition-specific evidence base for statin-associated muscle symptoms and mitochondrial disorders.
What safety findings are reported for methylene blue?
Methylene blue has MAO-inhibiting activity and can trigger serotonin syndrome when combined with SSRIs, SNRIs, or other serotonergic drugs. Material sold outside pharmaceutical channels can also differ in purity. These interaction and quality concerns contribute to its low Safety score.
Do NAD+ boosters give you more energy?
They reliably raise NAD+ levels, but the translation to noticeable energy or performance in healthy people is not well supported by human trials. The mechanism is real; the felt benefit is, so far, mostly unproven.
Scores reflect the published evidence, not a recommendation to use any compound or protocol. Nothing here is medical advice. How we score →